Cite
MLA Citation
Lewis L. Hsu et al.. “A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study.” American journal of hematology, vol. 93, no. 12, n.d., pp. 1493–1500. http://access.bl.uk/ark:/81055/vdc_100072165775.0x000044